Literature DB >> 46840

Effects of complement depletion in experimental chagas disease: immune lysis of virulent blood forms of Trypanosoma cruzi.

D B Budzko, M C Pizzimenti, F Kierszenbaum.   

Abstract

In mice infected with virulent blood (trypomastigote) forms of Trypanosoma cruzi, complement depletion with cobra venom factor caused a marked exacerbation of the disease evidenced by significantly increased parasitemia levels and early mortality as compared with those of untreated infected animals. The effect was greater in mice receiving cobra venom factor on day 7 postinfection, i.e., at the time when the parasites had had time to localize and multiply in the tissues and appeared in the circulation in appreciable numbers. The possibility that complement participates in host defense against T. cruzi infection through a mechanism involving immune lysis was explored in vitro. T. cruzi trypomastigotes were found to undergo immune lysis in sera of patients with chronic Chagas' disease, in sera of immunized mice, and in solutions containing both immune mouse gamma globulin and a source of active complement. This phenomenon failed to take place either in the absence of complement or after complement inactivation by heat or utilizing complement inactivators. The lytic capacity of heated sera was restored by the addition of active complement to the system. During the immune lysis of T. cruzi blood forms, complement was activated in human sera via both the classical and the alternate pathways. In mouse sera, activation followed at least the alternate pathway.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 46840      PMCID: PMC415029          DOI: 10.1128/iai.11.1.86-91.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  Purification and properties of the phytohemagglutinin of Phaseolus vulgaris.

Authors:  D A RIGAS; E E OSGOOD
Journal:  J Biol Chem       Date:  1955-02       Impact factor: 5.157

2.  [Lytic effect of normal sera on cultured and sanguineous forms of Trypanosoma cruzi].

Authors:  M RUBIO
Journal:  Bol Chil Parasitol       Date:  1956 Oct-Dec

3.  Phagocytosis: a defense mechanism against infection with Trypanosoma cruzi.

Authors:  F Kierszenbaum; E Knecht; D B Budzko; M C Pizzimenti
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

4.  Isolation of the anticomplementary protein from cobra venom and its mode of action on C3.

Authors:  H J Müller-Eberhard; K E Fjellström
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

5.  The immunology of experimental Chagas' disease. I. Preparation of Trypanosoma cruzi antigens and humoral antibody response to there antigens.

Authors:  A R Teixeira; C A Santos-Buch
Journal:  J Immunol       Date:  1974-09       Impact factor: 5.422

6.  C3 shunt activation in human serum chelated with EGTA.

Authors:  D P Fine; S R Marney; D G Colley; J S Sergent; R M Des Prez
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

7.  The effects of bacterial endotoxin on the infection of mice with Trypanosoma cruzi.

Authors:  F Kierszenbaum; L E Saavedra
Journal:  J Protozool       Date:  1972-11

8.  [Sensitivity of serological tests in the diagnosis of Chagas' disease].

Authors:  J A Cerisola; M Alvarez; H Lugones; J B Rebosolán
Journal:  Bol Chil Parasitol       Date:  1969 Jan-Mar

9.  Role of complement in immune lysis of Trypanosoma cruzi.

Authors:  D F Anziano; A P Dalmasso; R Lelchuk; C Vásquez
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

  9 in total
  33 in total

Review 1.  Chagas' disease and the autoimmunity hypothesis.

Authors:  F Kierszenbaum
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  Induction of capping in blood-stage trypomastigotes of Trypanosoma cruzi by human anti-Trypanosoma cruzi antibodies.

Authors:  G A Schmuñis; A Szarfman; T Langembach; W de Souza
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

3.  [Immunologic reaction in parasitic invasion (author's transl)].

Authors:  O Zwisler
Journal:  Z Parasitenkd       Date:  1977-06-03

4.  Modulation of sensitivity of blood forms of Trypanosoma cruzi to antibody-mediated, complement-dependent lysis.

Authors:  F Kierszenbaum; M A Ramirez
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

5.  Trypanosoma cruzi infection in rats induced early lesion of the heart noradrenergic nerve terminals by a complement-independent mechanism.

Authors:  C R Machado; D A de Oliveira; M J Magalhaes; E M Carvalho; F J Ramalho-Pinto
Journal:  J Neural Transm Gen Sect       Date:  1994

6.  Isotype of lytic antibodies in serum of Chagas' disease patients.

Authors:  S A Romeiro; H A Takehara; I Mota
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

7.  Complement in experimental Trypanosoma lewisi infection of rats.

Authors:  J A Jarvinen; A P Dalmasso
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

8.  Purification of a Trypanosoma cruzi membrane glycoprotein which elicits lytic antibodies.

Authors:  K A Norris; G Harth; M So
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

9.  Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice.

Authors:  Marianne A Bryan; Siobhan E Guyach; Karen A Norris
Journal:  PLoS Negl Trop Dis       Date:  2010-07-06

10.  Improved method for in vitro secondary amastigogenesis of Trypanosoma cruzi: morphometrical and molecular analysis of intermediate developmental forms.

Authors:  L A Hernández-Osorio; C Márquez-Dueñas; L E Florencio-Martínez; G Ballesteros-Rodea; S Martínez-Calvillo; R G Manning-Cela
Journal:  J Biomed Biotechnol       Date:  2009-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.